Home > TV
US remake of 'Good Doctor' set for premier this month
A promotional image for ABC's upcoming TV series "The Good Doctor" (Sony Pictures Television) |
The American adaptation of the show, titled "The Good Doctor," is scheduled to premier on Sept. 25 on ABC, according to the network and producers. The weekly show is the first remake of South Korean source material to get prime time treatment.
The original South Korean show was aired on KBS 2TV from August to November of 2013. The show, starring Joo Won, Moon Chae-won and Joo Sang-wook, centers on a young autistic savant surgeon who is recruited into the surgical unit of a prestigious hospital.
(KBS) |
"We also pitched the show to NBC, CBS, FOX and Netflix and eventually partnered with ABC as the company offered better terms," said Yu.
He added, "More than 100 TV shows are pitched to networks around January, when pilots are decided for production. Normally around eight shows are chosen. 'The Good Doctor' was chosen among those."
The project was once affiliated with CBS until the network abandoned it in January 2015. But the local production company 3AD, headed by Korean-American actor Daniel Dae Kim, continued to pursue the shows and landed a deal with ABC. Kim later hired award-winning screenwriter David Shore, who created shows such as "NYPD Blue" and "House."
A still from ABC's upcoming TV series "The Good Doctor" (Sony Pictures Television) |
ABC series "Somewhere Between," which is currently being aired, is the first US TV show adapted from South Korean source material -- the murder mystery is based on SBS TV's "God's Gift: 14 Days."
But "The Good Doctor" is significant in the fact that it is the first remake of a South Korean work included in the fall season lineup of a major network, which normally has shows that are bigger and more expensive than shorter summer TV shows that usually end with just one season.
"I experienced that winning a slot for the fall TV lineup at a US broadcaster was near-impossible to get, but with the American market it is very important and we must continue to pursue it, especially with the Chinese market blocked," said Yu. (Yonhap)